Verastem Sales per Share from 2010 to 2024

VSTM Stock  USD 11.82  0.23  1.98%   
Check Verastem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Verastem main balance sheet or income statement drivers, such as Depreciation And Amortization of 58.9 K, Interest Expense of 5 M or Selling General Administrative of 35.8 M, as well as many exotic indicators such as Price To Sales Ratio of 35.54, Dividend Yield of 1.0E-4 or Price Book Value Ratio of 1.17. Verastem financial statements analysis is a perfect complement when working with Verastem Valuation or Volatility modules.
  
This module can also supplement Verastem's financial leverage analysis and stock options assessment as well as various Verastem Technical models . Check out the analysis of Verastem Correlation against competitors.
To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.

About Verastem Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Verastem income statement, its balance sheet, and the statement of cash flows. Verastem investors use historical funamental indicators, such as Verastem's Sales per Share, to determine how well the company is positioned to perform in the future. Although Verastem investors may use each financial statement separately, they are all related. The changes in Verastem's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Verastem's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Verastem Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Verastem. Please read more on our technical analysis and fundamental analysis pages.
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. The company was incorporated in 2010 and is headquartered in Needham, Massachusetts. Verastem operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Verastem is a strong investment it is important to analyze Verastem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verastem's future performance. For an informed investment choice regarding Verastem Stock, refer to the following important reports:
Check out the analysis of Verastem Correlation against competitors.
To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for Verastem Stock analysis

When running Verastem's price analysis, check to measure Verastem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verastem is operating at the current time. Most of Verastem's value examination focuses on studying past and present price action to predict the probability of Verastem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verastem's price. Additionally, you may evaluate how the addition of Verastem to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Is Verastem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.96)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.47)
Return On Equity
(1.39)
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.